Damora Therapeutics
DMRANasdaq DenmarkHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$1.354 B
$21.87 -4.66%
Close of 6 Nov 2026
As of 6 Nov 2026, Damora Therapeutics (DMRA) has a market capitalization of $1.35B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$209.8M
Loss-making
Shares outstanding
61,904,742
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #124InnovivaINVA$1.37B
- #125Structure TherapeuticsGPCR$1.35B
- #126Damora TherapeuticsDMRA$1.35B
- #127Mineralys TherapeuticsMLYS$1.35B
- #128AnaptysbioANAB$1.35B
What if Damora Therapeutics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Damora Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.